EXHIBIT 10.44
February 28, 2002
Xxxxx Xxxx
Vice President, Platform Technology
Millennium Pharmaceuticals, Inc.
00 Xxxxxx Xxxxxx
Xxxxxxxxx, XX 00000
RE: Amendment Number 2 to Technology Access and Applications Development
Agreement between Millennium Pharmaceuticals, Inc. and Caliper
Technologies Corp. effective March 24, 2000
Dear Xxxxx:
Reference is made to the Technology Access and Applications Development
Agreement by and between Millennium Pharmaceuticals, Inc. ("MPI") and Caliper
Technologies Corp. ("Caliper") effective as of March 24, 2000, as amended
effective December 18, 2001 (collectively, the "Agreement").Capitalized terms
used in this Amendment Number 2 (the "Amendment No. 2") but not defined shall
have the meaning ascribed to such terms in the Agreement.
The purpose of this Amendment No. 2 is to evidence the agreement of MPI
and Caliper to extend the term of the Agreement to permit the continuation of
ongoing Feasibility NAP Plans and to continue to negotiate in good faith, the
terms of the Definitive Agreement.
1. Extension of Term.
Pursuant to Section 10.5 of the Agreement, the Agreement shall expire on
June 30, 2002
2. General.
Except as expressly modified by this Amendment No. 2, all other terms
and conditions of the Agreement shall remain in full force and effect. The
Agreement and this Amendment No. 2 constitute the entire and only agreement
between the parties relating to the subject matter hereof, and all prior and
interim negotiations, representations, agreements and understandings are
superseded by the Agreement and this Amendment No. 2.
This Amendment No. 2 may be executed in any number of counterparts, each
of which shall be deemed an original but all of such together shall constitute
one and the same instrument.
Please signify your agreement with the foregoing terms by countersigning
this Amendment No. 2 in the space provided below.
Sincerely Yours,
CALIPER TECHNOLOGIES CORP.
By: /s/ Xxxxxxx X. Xxxxx
---------------------------------------
Name: Xxxxxxx X. Xxxxx
Title: VP Corporate Development
Agreed to:
MILLENNIUM PHARMACEUTICALS, INC.
By: /s/ Xxxxx X. Xxxx
---------------------------------------
Name: Xxxxx X. Xxxx
Title: Vice-President, Platform Technology
